Evidence map›Paper›PMID 34752621›Full record

Observational studyThe Journal of clinical endocrinology and metabolism2022

Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.

Soren Harnois-Leblanc, Maria Isabel Hernandez, Ethel Codner, Fernando Cassorla, Sharon E Oberfield, Natasha I Leibel, Revi P Mathew, Svetlana Ten, Denis A Magoffin, Christianne J Lane and 4 more

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 4 countries.

Soren Harnois-LeblancResearch Center, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.ORCID 0000-0001-5894-976X
Maria Isabel HernandezDepartment of Preventive and Social Medicine, School of Public Health, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
Ethel CodnerInstituto de Investigaciones Materno Infantil, School of Medicine, University of Chile, Santiago, Chile.ORCID 0000-0002-2899-2705
Fernando CassorlaInstituto de Investigaciones Materno Infantil, School of Medicine, University of Chile, Santiago, Chile.
Sharon E OberfieldDepartment of Pediatrics, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0001-9652-1107
Natasha I LeibelDepartment of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Revi P MathewDivision of Pediatric Endocrinology, School of Medicine, Vanderbilt University, Nashville, TN, USA.
Svetlana TenRichmond University Medical Center, Staten Island, NY, USA.ORCID 0000-0002-2565-0400
Denis A MagoffinDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Christianne J LaneDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Michael I GoranCenter for Endocrinology, Diabetes and Metabolism, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-6897-6961
Ricardo AzzizDepartments of Obstetrics and Gynecology, and Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, ALUSA.ORCID 0000-0002-3917-0483
Jean-Patrice BaillargeonResearch Center, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.ORCID 0000-0002-1336-081X
David H GellerCenter for Endocrinology, Diabetes and Metabolism, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-1732-5034
University of Southern California · USColumbia University Irving Medical Center · USUniversity of Chile · CLCedars-Sinai Medical Center · USCentre Hospitalier Universitaire de Sherbrooke · CAGovernment of Western Australia Department of Health · AURichmond University Medical Center · USUniversité de Montréal · CAUniversité de Sherbrooke · CAVanderbilt University · US

Funding

ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ANDERSON, GAIL V · 1985 to 2011
$74.2M
TYPE 2 DIABETES IN HISPANIC ADOLESCENTSR01DK059211 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GORAN, MICHAEL ISAAC · 2000 to 2013
$9.2M
Insulin Resistance in Adolescents at High Risk for PCOSK23HD040325 · NICHD · CEDARS-SINAI MEDICAL CENTER · PI GELLER, DAVID HARRY · 2001 to 2005
$607k
NCRR NIH HHS M01 RR000425NICHD NIH HHS K23 1HD40325NICHD NIH HHS K23 HD040325NIDDK NIH HHS RO1 59211
6 · The paper itself

Abstract

contextFirst-degree relatives of women with polycystic ovary syndrome (PCOS) present hormonal and metabolic alterations compared to girls unrelated to PCOS. It is unknown whether glucose intolerance in the PCOS proband confers a more severe metabolic predisposition on their first-degree relatives.

objectiveTo determine whether glucose tolerance status in women with PCOS is associated with worsened glucose metabolism and sex hormone levels in their peripubertal daughters or sisters.

designCross-sectional study.

settingSeven academic centers in North America, South America, and Europe. PATIENTS: Sixty-four pairs of women with PCOS and their daughters or younger sisters aged between 8 and 14 years were recruited. Twenty-five mothers or older sisters with PCOS were glucose intolerant (GI) and 39 were normal glucose tolerant (NGT).

main outcome measuresBeta-cell function estimated by the insulin secretion-sensitivity index-2 (ISSI-2) during an oral glucose tolerance test and by the disposition index during a frequently sampled IV glucose tolerance test. Free testosterone and 17-hydroxyprogesterone (17-OHP) levels.

resultsBeing related to a GI PCOS proband was associated with a lower ISSI-2 (P-value = 0.032) after adjusting for ethnicity, body mass index z-score, and pubertal stage. They also had higher free testosterone (P-value = 0.011) and 17-OHP levels compared to girls with an NGT proband, the latter becoming significant after adjusting for confounders (P-value = 0.040).

conclusionsCompared to first-degree female relatives of women with PCOS and NGT, first-degree relatives of women with PCOS and GI display lower beta-cell function and hyperandrogenemia, putting them at higher risk of GI and PCOS development.

Indexed as

AdolescentAndrogensChildCross-Sectional StudiesFemaleGlucoseGlucose IntoleranceGlucose Tolerance TestHumansInsulinInsulin ResistanceInsulin-Secreting CellsNuclear FamilyOvaryPolycystic Ovary SyndromeRisk FactorsAndrogensGlucoseInsulinadolescentfirst-degree relativesglucose homeostasispediatricpolycystic ovary syndromesex hormones

Identifiers

PMID34752621
PMCPMC8851929
OpenAlexW3212528073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.